Management of osteoporosis

Table 7 Bone Density Response to Therapy.

Generic Name	Brand Name	Spine	Hip
Estrogen	Various
Alendronate	Fosamax
Risedronate	Actonel
Ibandronate	Boniva
Calcitonin	Miacalcin	-	-
Raloxifene	Evista
Teriparatide	Forteo

This table illustrates direction of change in bone mineral density (BMD) with each type of drug. This does not represent a comparison of the magnitude of BMD change with different drugs. All of the medications that are currently approved by the FDA, with the exception of salmon calcitonin, have been shown to increase BMD at both the spine and hip.

ISSN: 1476-7961